Biohaven (BHVN) Cash from Financing Activities (2021 - 2026)

Biohaven has reported Cash from Financing Activities for 6 years, with the latest figure at $179.0 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 48413.82% year-over-year to $179.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $617.8 million (down 8.44% YoY) and the FY2025 annual result came in at $439.1 million, down 35.21% from the prior year.
• Cash from Financing Activities declined to $179.0 million in Q1 2026 per BHVN's latest filing, from $188.8 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $530.2 million in Q4 2022 and troughed at -$39.7 million in Q3 2023.
• A 5-year average of $133.8 million and a median of $86.8 million in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities tumbled 131.09% in 2023, then soared 48413.82% in 2026.
• Over 5 years, Cash from Financing Activities stood at $530.2 million in 2022, then sank by 53.74% to $245.2 million in 2023, then increased by 11.26% to $272.9 million in 2024, then tumbled by 30.81% to $188.8 million in 2025, then slipped by 5.18% to $179.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $179.0 million, $188.8 million, and $122000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.